DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management Essentially all ...

(CNN) — A budget proposal for the US Department of Health and Human Services details extensive cuts to funding for the National Institutes of Health, part of an effort to consolidate the work of its ...

The proposed budget reduces HHS discretionary funding by $31 billion, with a 40% cut for NIH, marking its lowest funding in decades. NIH restructuring consolidates 27 institutes into 8 new entities, ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been awarded a ...

Proposed legislation, should it make its way through Congress, would dismantle the National Institute of Allergy and Infectious Diseases (NIAID) as it currently exists, replacing it with three ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. The National Institutes of Health on Friday announced six acting directors to run ...

South Korean biotech startup HTnB Inc. said Tuesday it has partnered with U.S. federal agencies to develop a next-generation medical countermeasure for radiation exposure. HTnB signed a non-clinical ...

Multiple sources, in different parts of the National Institutes of Health, used the word “bloodbath” to describe what was happening on Tuesday. Though it isn’t necessarily a surprise, given Health and ...